Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages

Table 2

Anthropometric and biochemical characteristics and clinical stage of patients with PTC depending on the BMI.

	BMI < 25; 51 women, 0 men; (mean ± SD; median)	BMI ≥ 25; 100 women, 26 men; (mean ± SD; median)
Age	41.16 ± 11.86; 38	55.38 ± 12.68; 58	<0.001
BMI (kg/m^2)	21.75 ± 2.08; 21.45	30.65 ± 4.05; 30.11	<0.001
Waist (cm)	75.73 ± 8.29; 75	99.28 ± 11.21; 98	<0.001
WHR	0.78 ± 0.07; 0.78	0.90 ± 0.08; 0.89	<0.001
Glucose (mg/dL)	122.91 ± 24.72; 117	119.84 ± 25.77; 115	NS
TGs (mg/dL)	116.05 ± 48.35; 110	175.36 ± 69.99; 170	<0.001
HDL (mg/dL)	59.17 ± 18.60; 52	50.01 ± 18.65; 53	NS
Cholesterol (mg/dL)	249.41 ± 106.37; 212	287.47 ± 125.00; 232	NS
HOMA-IR	1.11 ± 0.67; 0.92	1.44 ± 1.03; 1.21	0.06
Adiponectin (μg/mL)	15.82 ± 6.67; 15.03	14.60 ± 6.23; 13.42	NS
Leptin (ng/mL)	8.54 ± 5.73; 7.18	22.25 ± 19.14; 18.84	<0.001
Chemerin [ng/mL]	211.74 ± 47.21; 214.50	229.27 ± 50.11; 223.00	<0.05
Vitamin D (nmol/L)	68.00 ± 23.99; 63.00	65.08 ± 22.84; 61.00	NS
IL-6 (pg/mL)	2.19 ± 0.80; 2.00	2.87 ± 1.01; 2.61	<0.001
N (%) of patients with microcarcinomas	32 (62.75)	62 (49.21)	NS
N (%) of patients with
Stage I	48 (94.12)	96 (76.19)	<0.01
Stage II	3 (5.88)	28 (22.22)	<0.01
Stage III	0	1 (0.79)
Stage IV	0	1 (0.79)

NS = not significant.